At INSIGHT Health, we provide real world evidence (RWE) along the entire patient journey to a wide range of healthcare stakeholders in order to increase transparency in the healthcare market. For researchers in particular, this data offers significant added value in order to be able to understand and evaluate the efficacy of drugs and the effectiveness of new therapies. Accordingly, everyday patterns such as adherence, comorbidities and comedications, or prescribing behavior of practitioners are taken into account through the use of real world data, which cannot be fully mapped in clinical trial research.
INSIGHT Health and CGM offer partners solutions, among others for patient recruitment for studies or retrospective observational studies or the support of product launches. RWE thereby provides enormous benefits, for example in the faster market approval of new therapies.